161 related articles for article (PubMed ID: 26979528)
1. Disease-specific clinical trials networks: the example of cystic fibrosis.
De Boeck K; Bulteel V; Fajac I
Eur J Pediatr; 2016 Jun; 175(6):817-24. PubMed ID: 26979528
[TBL] [Abstract][Full Text] [Related]
2. Guideline on the design and conduct of cystic fibrosis clinical trials: the European Cystic Fibrosis Society-Clinical Trials Network (ECFS-CTN).
De Boeck K; Bulteel V; Tiddens H; Wagner T; Fajac I; Conway S; Dufour F; Smyth AR; Lee T; Sermet I; Kassai B; Elborn S;
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S67-74. PubMed ID: 21658644
[TBL] [Abstract][Full Text] [Related]
3. The cystic fibrosis therapeutics development network (CF TDN): a paradigm of a clinical trials network for genetic and orphan diseases.
Goss CH; Mayer-Hamblett N; Kronmal RA; Ramsey BW
Adv Drug Deliv Rev; 2002 Dec; 54(11):1505-28. PubMed ID: 12458158
[TBL] [Abstract][Full Text] [Related]
4. Clinical trials in cystic fibrosis.
Döring G; Elborn JS; Johannesson M; de Jonge H; Griese M; Smyth A; Heijerman H;
J Cyst Fibros; 2007 Apr; 6(2):85-99. PubMed ID: 17350898
[TBL] [Abstract][Full Text] [Related]
5. Is the raised volume rapid thoracic compression technique ready for use in clinical trials in infants with cystic fibrosis?
Matecki S; Kent L; de Boeck K; Le Bourgeois M; Zielen S; Braggion C; Arets HG; Bradley J; Davis S; Sermet I; Reix P;
J Cyst Fibros; 2016 Jan; 15(1):10-20. PubMed ID: 25890589
[TBL] [Abstract][Full Text] [Related]
6. Measuring health-related quality of life in clinical trials in cystic fibrosis.
Abbott J; Hart A; Havermans T; Matossian A; Goldbeck L; Barreto C; Bergsten-Brucefors A; Besier T; Catastini P; Lupi F; Staab D
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S82-5. PubMed ID: 21658648
[TBL] [Abstract][Full Text] [Related]
7. Gene therapy for cystic fibrosis in humans by liposome-mediated DNA transfer: the production of resources and the regulatory process.
Caplen NJ; Gao X; Hayes P; Elaswarapu R; Fisher G; Kinrade E; Chakera A; Schorr J; Hughes B; Dorin JR
Gene Ther; 1994 Mar; 1(2):139-47. PubMed ID: 7584070
[TBL] [Abstract][Full Text] [Related]
8. Procedures and methods of benefit assessments for medicines in Germany.
Bekkering GE; Kleijnen J
Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
[TBL] [Abstract][Full Text] [Related]
9. EuroCareCF: working together to improve patient care and therapy development.
Sheppard DN
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S1-4. PubMed ID: 21658628
[No Abstract] [Full Text] [Related]
10. Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosis.
Elborn JS; Bell SC; Madge SL; Burgel PR; Castellani C; Conway S; De Rijcke K; Dembski B; Drevinek P; Heijerman HG; Innes JA; Lindblad A; Marshall B; Olesen HV; Reimann AL; Solé A; Viviani L; Wagner TO; Welte T; Blasi F
Eur Respir J; 2016 Feb; 47(2):420-8. PubMed ID: 26453627
[TBL] [Abstract][Full Text] [Related]
11. Cooperation is key, say neuromuscular-disease researchers.
Butcher J
Lancet Neurol; 2007 Apr; 6(4):298-9. PubMed ID: 17438644
[No Abstract] [Full Text] [Related]
12. Developing new products in cystic fibrosis: needs and obstacles for activities of small and middle-sized companies.
Schlangen M; Reimann AL
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S103-9. PubMed ID: 21658629
[TBL] [Abstract][Full Text] [Related]
13. Use of nonviral vectors for cystic fibrosis gene therapy.
Alton EW;
Proc Am Thorac Soc; 2004; 1(4):296-301. PubMed ID: 16113449
[TBL] [Abstract][Full Text] [Related]
14. [Cystic fibrosis: new treatments targeting the CFTR protein].
Fajac I; Sermet-Gaudelus I
Rev Mal Respir; 2013 Apr; 30(4):255-61. PubMed ID: 23664284
[TBL] [Abstract][Full Text] [Related]
15. New pulmonary therapies for cystic fibrosis.
Ratjen F
Curr Opin Pulm Med; 2007 Nov; 13(6):541-6. PubMed ID: 17901762
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of repeat administration of a replication deficient, recombinant adenovirus containing the normal cystic fibrosis transmembrane conductance regulator cDNA to the airways of individuals with cystic fibrosis.
Crystal RG; Mastrangeli A; Sanders A; Cooke J; King T; Gilbert F; Henschke C; Pascal W; Herena J; Harvey BG
Hum Gene Ther; 1995 May; 6(5):667-703. PubMed ID: 7578402
[No Abstract] [Full Text] [Related]
17. A research roadmap for complementary and alternative medicine - what we need to know by 2020.
Fischer F; Lewith G; Witt CM; Linde K; von Ammon K; Cardini F; Falkenberg T; Fønnebø V; Johannessen H; Reiter B; Uehleke B; Weidenhammer W; Brinkhaus B
Forsch Komplementmed; 2014; 21(2):e1-16. PubMed ID: 24851850
[TBL] [Abstract][Full Text] [Related]
18. The European cystic fibrosis patient registry: the power of sharing data.
Sheppard DN
J Cyst Fibros; 2010 Dec; 9 Suppl 2():S1-2. PubMed ID: 20980207
[No Abstract] [Full Text] [Related]
19. A new Clinical Trials Directive to boost academic trials?
De Boeck K; Tiddens H; Elborn S; Fajac I;
Lancet Respir Med; 2013 Apr; 1(2):99-101. PubMed ID: 24429080
[No Abstract] [Full Text] [Related]
20. Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.
Chopra R; Paul L; Manickam R; Aronow WS; Maguire GP
Expert Opin Drug Saf; 2015 Mar; 14(3):401-11. PubMed ID: 25604518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
